Progressive Care Launches ClearMetrX Data Analytics Service
June 30 2020 - 7:54AM
InvestorsHub NewsWire
Miami, FL -- June 30, 2020
-- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB:
RXMD) (“Progressive Care” or the “Company”), a personalized
healthcare services and technology company, today announced the
launch of ClearMetrX, the Company’s first wholly-owned data
analytics company with services designed to support health care
organizations across the
country.
The idea to consolidate data
analytics and reporting services in a separate, wholly-owned
subsidiary of the Company is based on the Company’s evaluation of
the data analytics and reporting tools in current pharmacy
operations. Over the past 9 months, the Company has generated over
$250,000 in data management fees with gross margins exceeding 80%.
By creating a separate entity for these services, the programs can
be delivered nationwide without the competitive pressures
associated with pharmacy. The new subsidiary will focus on
providing insights, data security, and technological development.
The Company plans to transition data service customers from the
pharmacies to the ClearMetrX platform to better scale the products
and improve the capabilities of existing analytics
options.
The core products of
ClearMetrX include data management and Third Party Administration
(TPA) services for Federally Qualified Health Centers (FQHCs),
Pharmacy Analytics, and programs to manage HEDIS Quality Measures
such as Medication Adherence. These offerings cater to the glaring
need by frontline providers to understand best practices, patient
behaviors, care management processes, and the financial mechanisms
behind these decisions. The Company aims not just to provide data
access, but actionable insights that providers and support
organizations can use to improve their practice and patient
care.
“I have long said that data
analytics and technology development need to be at the forefront of
our growth strategy,” said S. Mars, CEO. “With the launch of
ClearMetrX, we have taken another step forward in implementing that
strategy.”
For more information about
ClearMetrX, please visit www.ClearMetrX.com.
For more information about
Progressive Care, please visit the company’s
website.
Connect and stay in touch
with us on social media:
Progressive Care
Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star
RX
https://www.fivestarrx.com/
https://www.facebook.com/fivestarrx/
About Progressive Care
Inc.
Progressive Care Inc.
(OTCQB:
RXMD), through its subsidiaries is a personalized healthcare
services and technology company which provides prescription
pharmaceutical services, risk management and data analytics to
healthcare organizations and
providers.
About
ClearMetrX
ClearMetrX is a healthcare
technology company that provides a wide array of analytics and
reporting services.
Cautionary Statement
Regarding Forward-Looking
Statements
Statements contained herein
that are not based upon current or historical fact are
forward-looking in nature and constitute forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such
forward-looking statements reflect the Company’s expectations about
its future operating results, performance, and opportunities that
involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
“anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,”
“intend” and “expect” and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company’s
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor Relations
Contact:
Armen Karapetyan,
Progressive Care Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations
Contact:
Carlos Rangel
carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2023 to Apr 2024